Zygmunt S Derewenda

Title: Zygmunt S Derewenda: Innovator in Ebola Virus Research

Introduction

Zygmunt S Derewenda is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical research, particularly in the development of recombinant antibodies for the diagnosis and treatment of Ebola virus infections. His work has implications for public health and safety, especially in the context of viral outbreaks.

Latest Patents

Derewenda holds a patent for "Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein." This patent focuses on compositions and methods that utilize the boundaries of the C-terminal domains of nucleoprotein from the Zaire Ebola virus. The aim is to create highly stable recombinant protein antigens that can generate antibodies for effective diagnosis and treatment of Ebola virus infection. He has 1 patent to his name.

Career Highlights

Throughout his career, Zygmunt S Derewenda has worked with prestigious institutions, including the University of Chicago and the University of Virginia Patent Foundation. His research has been pivotal in advancing our understanding of viral proteins and their interactions, which is crucial for developing therapeutic strategies.

Collaborations

Derewenda has collaborated with esteemed colleagues such as Elena K Davydova and Anthony A Kossiakoff. These partnerships have enriched his research and contributed to the success of his innovative projects.

Conclusion

Zygmunt S Derewenda's work exemplifies the importance of innovation in the fight against infectious diseases. His contributions to the field of Ebola virus research highlight the critical role of inventors in advancing medical science and public health.